Extramedullary Disease in Multiple Myeloma · Фаза 2 · NCT06627751
Mezigdomide, Carfilzomib, Dexamethasone, Echocardiography
Roswell Park Cancer Institute · Open the brief
Leukemia, Myelomonocytic, Chronic · Фаза 2 · NCT07033598
Pacritinib, Hydroxyurea
Theradex · Open the brief
Acute Lymphoblastic Leukemia · Фаза 2 · NCT07227584
Blinatumomab, Oncaspar, Cyclophosphamide, Cytarabine
Dana-Farber Cancer Institute · Open the brief
Recurrent Mantle Cell Lymphoma · Фаза 2 · NCT07673367
Nemtabrutinib, Brexucabtagene autoleucel ( other names: brexu-cel , Tecartus)
Vanderbilt-Ingram Cancer Center · Open the brief
Lymphoma · Фаза 2 · NCT06218602 · Papers
Fecal Microbiota Transplantation, Chemotherapy, CAR-T Therapy
M.D. Anderson Cancer Center · Open the brief
B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 · Фаза 2 · NCT07224100
Cyclophosphamide, Doxorubicin, Etoposide, Filgrastim
University of Washington · Open the brief
Acute Myeloid Leukemia · Фаза 2 · NCT03737955
Gemtuzumab Ozogamicin, Quality-of-Life Assessment, Bone Marrow Aspiration, Biospecimen Collection
University of Washington · Open the brief
Acute Lymphocytic Leukemia (ALL) · Фаза 2 · NCT07053059
Obecabtagene autoleucel
M.D. Anderson Cancer Center · Open the brief
Lymphocytic Leukemia · Фаза 2 · NCT07566364
Mosunetuzumab
M.D. Anderson Cancer Center · Open the brief
Chronic Lymphocytic Leukemia · Фаза 2 · NCT06849713
Zanubrutinib, Sonrotoclax, Obinutuzumab, Tacabrutideg
Massachusetts General Hospital · Open the brief
Follicular Lymphoma · Фаза 2 · NCT05389293
Mosunetuzumab, Zanubrutinib
Memorial Sloan Kettering Cancer Center · Open the brief
T-cell Acute Lymphoblastic Leukemia · Фаза 2 · NCT06390319 · Papers
Dexamethasone, Vincristine, Daunorubicin, Calaspargase pegol
St. Jude Children's Research Hospital · Open the brief
Recurrent Acute Lymphoblastic Leukemia · Фаза 2 · NCT03136146
Bortezomib, Clofarabine, Cyclophosphamide, Dexamethasone
M.D. Anderson Cancer Center · Open the brief
Multiple Myeloma · Фаза 2 · NCT06207799
Elranatamab, Lenalidomide, Plerixafor, Melphalan
M.D. Anderson Cancer Center · Open the brief
Multiple Myeloma · Фаза 2 · NCT07284758
Cemsidomide, Dexamethasone
C4 Therapeutics, Inc. · Open the brief
Multiple Myeloma · Фаза 2 · NCT06483100
Elrantamab, clonoSEQ
Washington University School of Medicine · Open the brief
Clonal Cytopenia of Undetermined Significance · Фаза 2 · NCT05483010
Atorvastatin, Rosuvastatin
Washington University School of Medicine · Open the brief
Lymphoma · Фаза 2 · NCT05929612
Ultra Low Dose 4 Gy Radiation
M.D. Anderson Cancer Center · Open the brief
Acute Lymphoblastic Leukemia · Фаза 2 · NCT06533748 · Papers
Dexamethasone, Vincristine, Inotuzumab, Blinatumomab
St. Jude Children's Research Hospital · Open the brief
Large B-cell Lymphoma · Фаза 2 · NCT05464719 · Papers
Loncastuximab Tesirine
M.D. Anderson Cancer Center · Open the brief
Recurrent Multiple Myeloma · Фаза 2 · NCT05847569
Belantamab Mafodotin, Biospecimen Collection, Bone Marrow Aspirate, Bone Marrow Biopsy
Mayo Clinic · Open the brief
Cutaneous T-Cell Lymphoma · Фаза 2 · NCT06698822
tofacitinib 2% cream
M.D. Anderson Cancer Center · Open the brief
Refractory Diffuse Large B Cell Lymphoma (DLBCL) · Фаза 2 · NCT04792489
zamtocabtagene autoleucel (MB-CART2019.1), Cyclophosphamide, Fludarabine, Bendamustine
Miltenyi Biomedicine GmbH · Open the brief
Acute Myeloid Leukemia · Фаза 2 · NCT05442216
Tagraxofusp, Azacitidine, Venetoclax
Joshua Zeidner · Open the brief